Observation of hepatotoxic effects of 2-n-pentylaminoacetamide (Milacemide) in rat liver by a combined in vivo/in vitro approach

Archives of Toxicology

Volumn 71, Issue 5, 1997, Pages 271-282

  Rogiers, Vera ^a   Vandenberghe, Yves ^b   Vanhaecke, Tamara ^a   Geerts, Albert ^a   Callaerts, André ^a   Carleer, Jacqueline ^b   Roba, Jose ^b   Vercruysse, Antoine ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b Product Safety   (Belgium)

Author keywords

2 n Pentylaminoacetamide hydrochloride; Hepatocytes; Hepatotoxicity; Liver cells; Milacemide

Indexed keywords

FAT DROPLET; LIVER ENZYME; MILACEMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FOOD INTAKE; IN VITRO STUDY; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT GAIN; XENOBIOTIC METABOLISM;

7-ALKOXYCOUMARIN O-DEALKYLASE; ACETAMIDES; ANIMALS; ANTICONVULSANTS; BODY WEIGHT; CELL SURVIVAL; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2B1; EATING; EPOXIDE HYDROLASES; GLUTATHIONE TRANSFERASE; LIPID METABOLISM; LIVER; MALE; MIXED FUNCTION OXYGENASES; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; MACACA FASCICULARIS; RODENTIA;

EID: 0030986125     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050387     Document Type: Article

References (39)

1. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
2. Burke MD, Mayer RT (1974) Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab Dispos 2: 583-588
3. Carleer J, Debruyne E, Cavalier R, Hérin M, Burton E, Roba J (1992) Effect of milacemide on the liver in the cynomolgus monkey. Toxicol Lett Suppl 34: 243-244 [Abstr]
4. Christophe J, Kutzner R, Nguyen-Bui WD, Damien C, Chatelain P, Gillet C (1983) Conversion of orally administered 2-n-pentylaminoacetamide into glycinamide and glycine in the rat brain. Life Sci 33: 533-541
5. Cutler NR, Fakouhi TD, Smith WT, Hendrie HC, Matsuo F, Sramek JJ, Herting RL (1993) Evaluation of multiple doses of milacemide in the treatment of senile dementia of the Alzheimer type. J Geriatr Phychiatry 6: 115-119
6. Dysken MW, Fakouhi TD, Skare SS, Mendels J, Le Witt P, Hendrie HC, Venable TC (1992a) Milacemide: safety assessment in senile dementia of the Alzheimer type. Drug Dev Res 27: 67-72
7. Dysken MW, Mendels J, Le Witt P, Reisberg B, Pomara N, Wood J, Fakouhi TD (1992b) Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type. J Am Geriatr Soc 40: 503-506
8. Eadie MJ, Hooper WD, Dickinson RG (1988) Valproate-associated hepatotoxicity and its biochemical mechanisms. Med Toxicol 3: 85-106
9. Edwards AM, Glistak ML, Lucas CM, Wilson PA (1984) 7-Ethoxycoumarin deethylase activity as a convenient measure of liver drug metabolizing enzymes: regulation in cultured rat hepatocytes. Biochem Pharmacol 33: 1537-1546
10. Finkelstein JE, Hengemihle JM, Ingram DK, Petri HL (1994) Milacemide treatment in mice enhances acquisition of a Morris-type water maze task. Pharmacol Biochem Behav 49: 707-710
11. Gill S, Ota K, Hammock BD (1983) Radiometric assays for mammalian epoxide hydrolase and glutathione S-transferase. Anal Biochem 131: 273-282
12. Habig WG, Pabst MJ, Jacoby W (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139
13. Handelmann GE, Nevins ME, Mueller LL, Arnolde SM, Cordi AA (1989) Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnestic rodents. Pharmacol Biochem Behav 34: 823-828
14. Hong J, Pan J, Gonzalez FJ, Gelboin HV, Yang CS (1987) The induction of a specific form of cytochrome P-450 (P-450 j) by fasting. Biochem Biophys Res Commun 142: 1077-1083
15. Houtkooper MA, Van Oorschot CAEH, Rentmeester TW, Hoppener PJEA, Onkelinx C (1986) Double-blind study of milacemide in hospitalized therapy-resistant patients with epilepsy. Epilepsia 27: 255-262
16. Ioannides C, Parke DV (1986) The cytochrome P-450 I gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. Drug Metab Rev 22: 1-85
17. Janssens de Varebeke Ph, Pauwels G, Buyse C, David-Remade M, De Mey J, Roba J, Youdim MBH (1989) The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B. J Neurochem 53: 1109-1116
18. Janssens de Varebeke Ph, Schallauer E, Rausch WD, Riederer P, Youdim MBH (1990) Milacemide, the selective substrate and enzyme-activated specific inhibitor of monoamine oxidase B, increases dopamine but not serotonin in caudate nucleus of Rhesus monkey. Neurochem Int 17: 325-329
19. Kesterson JW, Granneman GR, Machinist JM (1984) The hepatotoxicity of valproic acid and its metabolites in rats. I . Toxicologic, biochemical and histopathologic studies. Hepatology 4: 1143-1152
20. Lipkin EW, Cooper C, Shipley RA (1978) The contribution of serum triglycerol to hepatic triacylglycerol turnover in the starved rat. Biochem J 172: 205-218
21. Lubet RA, Nims RW, Mayer RT, Cameron JW, Schechtman LM (1985) Measurement of cytochrome P-450 dependent dealkylation of alkoxyphenazones in hepatic S9s and hepatocyte homogenates: effects of dicumarol. Mutat Res 42: 127-131
22. Mc Danell RE, Mc Lean AEM (1974) Differences between small and large intestine and liver in the inducibility of microsomal enzymes in response to stimulation by phenobarbitone and beta-naphthoflavone in the diet. Biochem Pharmacol 33: 1977-1980
23. Moody DE, Silva MH, Hammock BD (1986) Epoxide hydrolysis in the cytosol of rat liver, kidney and testis. Biochem Pharmacol 35: 2073-2080.
24. Ndangiza A, Masson M, Palate B, Roba J (1992) Effect of fasting on the liver toxicity of a single oral dose of sodium valproate, 4-en valproic acid, pentenoic acid, pentanoic acid and 2-n-pentylaminoacetamide in the rat. Toxicol Lett [Suppl 1992]: 326 [Abstr]
25. Norton LC, Laxer KD, Schomer D, Osborn P (1986) Phase II study to evaluate the efficacy and safety of milacemide (CP 1552 S) in the treatment of complex partial seizures in adult patients. Epilepsia 27: 648 [Abstr]
26. Omura T, Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. J Biol Chem 239: 2370-2378
27. Rakotoamboa JL, Masson M, Palate B, Carleer J, Roba J (1994) Fasting for 24 h reveals liver microsteatosis after continuous i.v. infusion of milacemide in the rat. Arch Toxicol 68: 266-271
28. Roba J, Cavalier R, Cordi A, Gorissen H, Hérin M, Janssens de Varebeke P, Onkelinx C (1986) Milacemide- In: Meldrum BS, Porter RJ (eds) New anticonvulsant drugs. Libbey, London Paris, pp 179-180
29. Rogiers V, Paeme G, Vercruysse A, Bouwens L (1984) Procyclidine metabolism in isolated rat liver cells. In: Van Bezooijen CFA (ed) Pharmacological, morphological and physiological aspects of liver ageing, Eurage, Rijswijk, pp 121-126
30. Rogiers V, Vandenberghe Y, Vercruysse A (1985) Inhibition of gluconeogenesis by sodium valproate and its metabolites in isolated rat hepatocytes. Xenobiotica 15: 759-765
31. Rogiers V, Adriaenssens L, Vandenberghe Y, Gepts E, Callaerts A, Vercruysse A (1986) Critical evaluation of 7-ethoxycoumarin O-deethylase activity measurement in intact isolated rat hepatocytes. Xenobiotica 16: 817-826
32. Rogiers V, Vandenberghe Y, Callaerts A, Sonck W, Maes V, Vercruysse A (1988) The inducing and inhibiting effects of sodium valproate in vivo on the biotransformation systems of xenobiotics in isolated rat hepatocytes. Xenobiotica 18: 665-673
33. Rogiers V, Vandenberghe Y, Callaerts A, Sonck W, Vercruysse A (1990) Effects of dimethylsulphoxide on phase I and II biotransformation in cultured rat hepatocytes. Toxic In Vitro 4(45): 439-442
34. Semba J, Curzon G, Patsalos PN (1993) Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid. Br J Pharmacol 108: 1117-1124
35. van Dorsser W, Barris D, Cordi A, Roba J (1983) Anticonvulsant activity of milacemide. Arch Int Pharmacodyn 266: 239-249
36. Waltregny A, Onkelinx C (1993) Initial results with milacemide in epileptic patients. Neurol Psychiatr 6: 158-173
37. Weibel E, Stäubli W, Gnagi RH, Hess FA (1969) Correlated morphometric and biochemical studies on the liver cell. A morphometric model, stereologic methods and normal morphometric data for rat liver. J Cell Biol 42: 68-91
38. Wisse E, De Wilde A, De Zanger R (1984) Perfusion fixation of human and rat liver tissue for light and electron microscopy: a review and assessment of existing methods with special emphasis on sinusoidal cells and microcirculation. In: O'Hare AMF (ed) Science of biological specimen preparation. SEM, Chicago, pp 31-38
39. Wolff T, Guengerich P (1987) Rat liver cytochrome P-450 isoenzymes as catalysts of aldrin epoxidation in reconstituted monooxygenase systems and microsomes. Biochem Pharmacol 36: 2581-2588